CLASS II Drug recall · Reported 23 Dec 2020 · FDA Enforcement Report

Sildenafil Tablets USP 100 mg recalled by AVKARE

Avkare is recalling Sildenafil Tablets USP 100 mg, distributed nationwide in the US. The recall was initiated on 7 Dec 2020 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesLot: 36884 Exp. 03/2022
Quantity recalled38715 bottles

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-0167-2021
FDA event ID
86940
Recalling firm
Avkare, Pulaski, TN
Classification
Class II
Status
Terminated
Recall initiated
7 Dec 2020
FDA classified
16 Dec 2020
Reported
23 Dec 2020
Type
Voluntary: Firm initiated
Customers notified by
Letter

Timeline

7 Dec 2020Recall initiated by company
16 Dec 2020Classified by FDA+9 days
23 Dec 2020Published in enforcement report+7 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Product mix-up: Bottles of sildenafil and trazodone were inadvertently packaged together during bottling at a 3rd party facility.

Products marketed as supplements sometimes contain undeclared prescription drug ingredients such as sildenafil or sibutramine. These can interact dangerously with other medicines.

Product as listed by the FDA

Sildenafil Tablets USP 100 mg, Rx Only, 100-count Bottle, Manufactured for: AvKARE Pulaski, TN 38478, NDC 42291-748-01.

Where it was distributed

Nationwide within the U.S.

Nationwide

Questions about this recall

Why was it recalled?

Product mix-up: Bottles of sildenafil and trazodone were inadvertently packaged together during bottling at a 3rd party facility.

Which lots are affected?

Lot: 36884 Exp. 03/2022

Where was it sold?

Nationwide within the U.S.

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

Other products in this recall event

1 other product · FDA event 86940

This product is part of a recall event; the main page for the event is TraZODONE Hydrochloride Tablets USP 100 mg recalled by AVKARE.

ReportedClassRecallCompanyReasonWhere
CLASS ITraZODONE Hydrochloride Tablets USP 100 mg recalled by AVKAREAvkareHidden Drug IngredientsNationwide

More recalls from Avkare

All 62
ReportedClassRecallCompanyReasonWhere
DrugCLASS IIAmantadine HCl, Capsules, UPS, 100 mg dose recalled by AvKAREAmantadine HclAvKAREPotency & AssayNationwide
DrugCLASS IIRosuvastatin Tablets, USP, 10 mg recalled by AvKARERosuvastatinAvKAREPotency & AssayNationwide
DrugCLASS IINorgestimate and Ethinyl Estradiol Tablets recalled by AvKARENorgestimate And Ethinyl EstradiolAvKAREOtherNationwide
DrugCLASS IIchloroproMAZINE Hydrochloride Tablets, USP, 100 mg unit dose recalledChlorpromazine HydrochlorideAvKAREOtherNationwide
DrugCLASS IIchloroproMAZINE Hydrochloride Tablets, USP, 50 mg unit dose recalledChlorpromazine HydrochlorideAvKAREOtherNationwide

Other Sildenafil recalls

All 6